Evidence map›Paper›PMID 32260544›Full record

ArticleBiomolecules2020

Protective Effect of Palm Oil-Derived Tocotrienol-Rich Fraction Against Retinal Neurodegenerative Changes in Rats with Streptozotocin-Induced Diabetic Retinopathy.

Muhammad Zulfiqah Sadikan, Nurul Alimah Abdul Nasir, Renu Agarwal, Nafeeza Mohd Ismail

Open access · goldAbstract read
In one paragraph

Article in Biomolecules, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Diabetic retinopathy: emerging concepts of current and potential therapy.Naunyn-Schmiedeberg's archives of pharmacology · 2023
    Review
  5. Review
  6. Article
  7. The effect of palm oil-derived tocotrienol-rich fraction in preserving normal retinal vascular diameter in streptozotocin-induced diabetic rats.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Muhammad Zulfiqah SadikanCentre for Neuroscience Research (NeuRon), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor 47000, Malaysia.
Nurul Alimah Abdul NasirCentre for Neuroscience Research (NeuRon), Faculty of Medicine, Universiti Teknologi MARA, Sungai Buloh, Selangor 47000, Malaysia.
Renu AgarwalSchool of Medicine, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
Nafeeza Mohd IsmailSchool of Medicine, International Medical University, Bukit Jalil, Kuala Lumpur 57000, Malaysia.
IMU University · MYUniversiti Teknologi MARA · MY

Funding

Universiti Teknologi MARA internal grant and Malaysia Ministry of Education (MOE) grant 600-IRMI/DANA 5/3/BESTARI (P) (001/2018), 600-IRMI/DANA 5/3/BESTARI (P) (012/2018) and 600-IRMI/FRGS 5/3 (101/2019)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsApoptosisBody WeightCytoprotectionDiabetic RetinopathyGene Expression RegulationMalePalm OilRatsRats, Sprague-DawleyRetinaStreptozocinTocotrienolsVascular Endothelial Growth Factor APalm OilStreptozocinTocotrienolsVascular Endothelial Growth Factor Aangiogenesisapoptosisdiabetic retinopathystreptozotocintocotrienol-rich fraction

Identifiers

PMID32260544
PMCPMC7226502
OpenAlexW3015171311

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.